Written by Garret Grant Founder & Lead Researcher B.S
Driven by the GLP-1 revolution the extraordinary commercial success of glucagon-like peptide-1 receptor agonist drugs for diabetes and obesity the market was worth USD 84.2 billion in 2025 and is expected to grow at a CAGR of 14.74% to reach USD 196.5 billion by 2031
Reduces Inflammation and Pain Known as the best peptide for inflammation , BPC-157 has anti-inflammatory properties that help reduce joint pain and swelling after injury or surgery without harmful NSAIDs or steroids
Because the compound is a metal complex, the methods section needs to state which species was used, how the copper content was established, what the medium contained by way of copper, chelators and reductants, and whether a copper-salt control was run
Zhang W, Gan B, Wang T, Yang X, Xue Y, Zhong Y, He X, Peng X, et al